Utilization of recombinant adenovirus and dominant negative mutants to characterize hepatocyte nuclear factor

J D Fraser1, D Keller, V Martinez

  • 1Ligand Pharmaceuticals Inc., San Diego, California 92121, USA. jfraser@ligand.com

Related Concept Videos